A pilot trial of innohep (tinzaparin) low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients

被引：0
|
作者：
Bohlin, C [1 ]
Penne, K [1 ]
Lyons, P [1 ]
Vredenburgh, J [1 ]
机构：
[1] Duke Univ, Hlth Syst, Durham, NC USA
来源：
ONCOLOGY NURSING FORUM | 2005年 / 32卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [1] Prescription of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients
    Ambrosi, P
    Calise, G
    Villani, P
    Luccioni, R
    Bouvenot, G
    PRESSE MEDICALE, 2000, 29 (26): : 1447 - 1450
  • [2] Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin
    Andersen, Anita Sylvest
    Berthelsen, Jorgen G.
    Bergholt, Thomas
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (01) : 15 - 21
  • [3] Low-molecular-weight heparin: Prophylaxis and treatment of venous thromboembolism
    Pineo, GF
    Hull, RD
    ANNUAL REVIEW OF MEDICINE, 1997, 48 : 79 - 91
  • [4] Comparison of low-molecular-weight heparin and unfractionated heparin for venous thromboembolism prophylaxis in trauma patients
    Gowler, Aimee
    Erstad, Brian
    Tang, Andrew
    PHARMACOTHERAPY, 2013, 33 (05): : E52 - E52
  • [5] Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
    Christopoulou, Athina
    Ardavanis, Alexandros
    Papandreou, Christos
    Koumakis, Georgios
    Papatsimpas, Georgios
    Papakotoulas, Pavlos
    Tsoukalas, Nikolaos
    Andreadis, Charalambos
    Samelis, Georgios
    Papakostas, Pavlos
    Aravantinos, Gerasimos
    Ziras, Nikolaos
    Souggleri, Maria
    Kalofonos, Charalambos
    Samantas, Epameinondas
    Makrantonakis, Paris
    Pentheroudakis, Georgios
    Athanasiadis, Athanasios
    Stergiou, Helen
    Bokas, Alexandros
    Grivas, Anastasios
    Tripodaki, Elli-Sofia
    Varthalitis, Ioannis
    Timotheadou, Eleni
    Boukovinas, Ioannis
    ONCOLOGY LETTERS, 2022, 23 (04)
  • [6] Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients
    du Plessis, J. A.
    van Blydenstein, S. A.
    Wong, M.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (03): : 235 - 242
  • [7] A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients
    Gritsiouk, Yaroslav
    Hegsted, Damian A.
    Schlesinger, Piroska
    Gardiner, Stuart K.
    Gubler, Kelly D.
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (05): : 648 - 651
  • [8] Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a trial sequential analysis
    Hung, Kuo-Chuan
    Chen, I-Wen
    Liu, Ping-Hsin
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (03) : 1839 - 1840
  • [9] Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery
    Sawczuk, IS
    Williams, D
    Chang, DT
    CANCER INVESTIGATION, 2002, 20 (7-8) : 889 - 892
  • [10] Venous thromboembolism in a general hospital - An update with low molecular weight heparin prophylaxis
    Schulz, S. L.
    Kesselring, C.
    Seeberger, U.
    Andresen, D.
    VASA-JOURNAL OF VASCULAR DISEASES, 2007, 36 (01): : 17 - 22
12345